March 1, 2023Pharma Industry Consortium Completes Brain Wave Study of Ketamine Effects on Healthy VolunteersRead More
March 20, 2019Industry Consortium Launched to Qualify Biomarkers for Schizophrenia Drug DevelopmentRead More
February 16, 2016Neuronetrix brain scanning featured in Discovery Network documentary filmed at Jackson-Wink MMARead More
November 18, 2015Neuronetrix publishes peer-reviewed paper validating the clinical application of ERP biomarkers for use in Alzheimer’s diseaseRead More
October 29, 2015Neuronetrix joins big pharma to sponsor conference on Clinical Trials for Alzheimer’s DiseaseRead More
July 20, 2015Neuronetrix launches a new breakthrough system to diagnose patients with cognitive disorders at the Alzheimer’s Association conference in Washington DCRead More
July 16, 2015Neuronetrix to gain significant exposure with key Alzheimer’s stakeholders at AAICRead More
May 14, 2015Leading neuroscientists receive grant awards for innovative clinical research.Read More
February 19, 2015Neuronetrix receives FDA clearance to market COGNISION™ for use in the clinicRead More
November 7, 2014Neuronetrix has been selected by Anavex Life Sciences Corp. to support the upcoming Phase 2a clinical trial for ANAVEX 2-73Read More
Older Press Releases